Table 1.

Characteristics of CCS and control subjects.

Childhood Cancer Survivors
Age	Solid Tumors			Haematological Malignancies
Years	Subjects N°	Female/Male	End of therapy (years)	Subjects N°	Female/Male	End of therapy (years)
<10 (Group 1)	35	19/16	6 (1–9)	32	25/7	2 (1–6)
11–20 (Group 2)	48	18/30	10 (3–17)	38	16/22	4 (1–15)
21–40 (Group 3)	10	2/8	18 (4–25)	33	21/12	9 (2–26)
Total number	93			103
Controls
Age-Matched				Aged Controls
Years	Subjects N°		Female/Male	Years	Subjects N°	Female/Male
<10	29		14/15	41–60	27	22/5
11–20	25		15/10	61–80	27	10/17
21–40	25		15/10	>80	25	17/8
Total number	79				75